logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Pharmaceutical
Filter

Pharmaceutical

Categories

Sectors

Locations

Exchange

医疗保健精选——Astellas在日本提交roxadustat申请,OpGen携手大华基因展开冠状病毒测试服务

Healthcare Roundup – Astellas files application in Japan, OpGen up 6% on planned coronavirus testing service

Jan 30, 2020

Life Science

医疗保健精选——强生疫苗对决冠状病毒,Selecta Biosciences下跌5.17%

Healthcare Roundup – J&J enters coronavirus fray with planned vaccine, Selecta Biosciences -5.7%

Jan 29, 2020

Life Science

冠状病毒恐惧情绪,香港股市应声下跌近3%

Hong Kong Stock Market Dives Nearly 3% on Coronavirus Fears

Jan 29, 2020

Life Science

武汉冠状病毒

Update: Biopharmas Developing Products for Wuhan Coronavirus Outbreak

Jan 29, 2020

Life Science

加拿大AbCellera积极应对中国新型冠状病毒爆发

AbCellera Is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of Its DARPA P3 Program

Jan 28, 2020

Life Science

武汉的博沃生物与亚特兰大的GeoVax签署开发冠状病毒疫苗的意向书

Wuhan’s BravoVax Signs Letter of Intent with Atlanta’s GeoVax to Develop Coronavirus Vaccine

Jan 28, 2020

Life Science

医疗保健精选——Itamar拟发售3000万美元ADS,Hepion Pharma取得积极NASH数据

Healthcare Roundup  – Itamar -4.7% after filing for $30M ADS offering, Hepion Pharma +46% on positive NASH data

Jan 28, 2020

Life Science

Technology Roundup – Guidewire gains a rare bear, Apple shares hit by China’s coronavirus worries

Jan 27, 2020

Life Science

TILT Biotherapeutics签约中国普米斯生物,用TILT-123治疗癌症

TILT Biotherapeutics Signs a Licensing Deal with Biotheus, Inc for Cancer Therapy with Oncolytic Virus TILT-123

Jan 27, 2020

Life Science

Sorrento Therapeutics拒绝了价值近10亿美元的收购报价

Sorrento Therapeutics Rejects Acquisition Bid Worth Nearly $1 Billion

Jan 27, 2020

Life Science

Sunniva Inc. Announces Ceasing Operations Of Full-Scale Distributors, LLC

Jan 27, 2020

Life Science

基石药业

CStone announces first patient dosed in the global proof-of-concept study of CS1001 in combination with Bayer’s regorafenib

Jan 24, 2020

Life Science

医疗保健精选——Innovative Industrial Properties公开发行,拜耳减持CRISPR Therapeutics股份

Healthcare Roundup – Innovative Industrial Properties prices public offering, Bayer cuts stake in CRISPR Therapeutics

Jan 24, 2020

Life Science

中国Shineco签约太平洋岛国最大组织,探索工业麻商机

Shineco, Inc. Enters into Strategic Cooperation Agreement with Pacific Islands Trade & Investment Commission

Jan 24, 2020

Cannabis, Life Science

宝洁监测中国冠状病毒

Procter & Gamble says it is monitoring China coronavirus and its impact on travel, consumer confidence

Jan 23, 2020

Life Science

歌禮製藥ASC22有望成為HBV一流免疫療法

Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody

Jan 23, 2020

Life Science

和黄医药,默克扩大了许可协议

Healthcare Roundup – Chi-Med readies $110M, Merck expands licensing agreement

Jan 22, 2020

Life Science

专注女性健康的Mycovia Pharmaceuticals管理层“换血”

Mycovia Pharmaceuticals Expands Commercialization Team with Strategic New Hires

Jan 21, 2020

Life Science

  • ‹‹ Previous
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada